Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tuberculosis and HIV: a deadly interaction.

E Girardi1, D Goletti, G Antonucci

  • 1Epidemiologic Department, National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Rome, Italy. girardi@spallanzani.roma.it

Journal of Biological Regulators and Homeostatic Agents
|November 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bundibugyo virus disease: transmission dynamics, infectiousness and viral persistence.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Artificial intelligence for TB education and counselling: a modified Delphi consensus.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

The Empty Medicine Cabinet: Urgent Action Needed to Resolve TB Drug Shortages in Europe.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2025
Same author

Evaluating the impact of COVID-19 or SARS-CoV-2 vaccination on TB infection testing in the context of TB elimination.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Calorie-restriction treatment mitigates the aging in rat liver model.

Biogerontology·2025
Same author

Kinetics of the humoral and cellular immune response up to 1 year from mpox virus infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025

The human immunodeficiency virus (HIV) epidemic fuels the global tuberculosis (TB) resurgence, particularly in poorer nations. Addressing HIV-associated TB requires urgent international commitment to innovative diagnostics, treatments, and integrated prevention programs.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The global resurgence of tuberculosis (TB) is significantly linked to the spread of the human immunodeficiency virus (HIV) epidemic.
  • In 1997, an estimated 8% of global TB cases were attributed to HIV infection, with the highest burden in resource-poor countries.
  • HIV impairs immune responses, increasing susceptibility to mycobacterial infections and complicating TB diagnosis and treatment.

Purpose of the Study:

  • To highlight the critical link between HIV and TB epidemics.
  • To underscore the challenges in diagnosing and treating HIV-associated TB.
  • To advocate for international commitment to combatting HIV-associated TB.

Main Methods:

  • Literature review and epidemiological data analysis (implied).

Related Experiment Videos

  • Assessment of the impact of HIV on TB susceptibility and disease progression.
  • Evaluation of diagnostic and treatment challenges in co-infected individuals.
  • Main Results:

    • HIV is a primary driver of the global TB epidemic.
    • HIV-associated TB disproportionately affects low-resource settings.
    • Co-infection presents significant diagnostic and therapeutic hurdles.

    Conclusions:

    • Urgent international collaboration is essential to develop innovative strategies for HIV-associated TB.
    • Integration of HIV and TB prevention programs is crucial.
    • Novel approaches to diagnosis, treatment, and prevention are urgently needed to mitigate the threat of HIV-associated TB.